Changes in appetite and weight were recorded in mild to moderately depressed out-patients during the course of clinical trials of various antidepressant drugs. After six weeks, differences due to treatment regimes were minimal. Patients who on becoming depressed experienced severe changes in appetite and weight in either direction, tended to return to normal. The significant associations of appetite and weight change during treatment were with weight, appetite, and carbohydrate preference at presentation, and also with the â€˜¿ appetite history' and â€˜¿ weight history'. The associations with the degree of depression were relatively minor.
uncertain origin. Clinically, increase in appetite and weight is generally regarded as a favourable sign during treatment of patients presenting with more severe â€˜¿ endogenous depression' . The converse may apply in those patients where depression is characterised by over-eating and weight gain. This has been recorded in individual cases, or in small groups (Bruch, 1974; Polivy & Herman 1976) , but not in a population of depressives.
Long-term antidepressant drug treatment may be associated with marked weight gain and carbohydrate craving (Paykel, 1973) . This effect must be partly due to pharmacological effects on the drive and satiety centres of the hypothalamus. It has been suggested (Crisp, 1980) that the stimulant effect of tricyclic antidepressants on appetite may be an important part of their antidepressant action. This is a difficult hypothesis to test, since it is not easy to decide whether mood change precedes alteration in appetite or vice versa. Antidepressants may also affect appetite control in either direction; amphetamines, for example, are known to have a temporary mood-elevating effect, but suppress appe tite. Similarly, newer antidepressants such as zimelidine, which act by 5 H.T. potentiation, have also been noted to have an anorectic action (Gottfries, 1981) . It was therefore felt worthwhile to look at groups of patients taking antidepressant drugs who before treatment have opposite changes in appetite and weight. If the group who had increased appetite and increased weight on becoming depressed return to their normal appetite and weight with treatment, it is difficult to see how the action of tricyclic antidepressants could be explained by their action on appetite, at least in this particular group of patients.
Method
One hundred and sixty-eightmild to moderately depressed out-patients (Hamilton scores ranged from 12 to 50), were assessed for a period of six weeks, while completing antidepressant trials. All had satisfied Feighner's criteria for primary depressive illness (Feighner et a!, 1972) . The depression was rated using the Hamilton, MRC, and Beck scales and in addition, the presence of various symptoms was measured using the Middlesex Hospital Questionnaire (MHQ). Appetite was recorded in comparison to normal, and changes in appetite (in either direction) were rated on a seven-point linear scale. Particular interest in carbohydrate containing foodstuffs was rated as normal or increased on a three-point linear scale. Each patient was weighed at presentation and after six weeks of treatment.
Appetite history was defined as changes in appetite occurring with stress when the patient was quite well. It was measured on a linear scale with a mid-point of â€˜¿ no change' and mild, moderate, and severe increase or decrease on either side. Severe changes represented eating twice as much as normal or half as much as normal respectively over the course of a day. Similarly, weight history was estimated linearly, with extreme steady weightat one end of the scale (weightchange of lessthan 3 lbsin a year) and extreme unsteadyweightat the other (weight change of 12 lbs or more in a year).
It should be noted that Hamilton and Beck scores were corrected throughout the study by extractions of that part of the score due to appetite and weight loss. The patients were on one of seven antidepressant regimes in double-blind trials, viz oral medication in identical capsule formâ€"amitriptyline, flupenthixol, pheneizine, isocar boxazid, trimipramine, trimipramine, and isocarboxazid in combination or trimipramine and phenelzine in combination (Youngeta!, 1976 (Youngeta!, ,1979 ScoresAppetiteâ€"0.350.001â€"0.750.001â€"0.300.001Weightâ€"0.200.01â€"0.230.001â€"0.05NSAppetite historyâ€"0.250.001â€"0.440.001â€"0.170.05Carbohydrate preferenceâ€"0.140.05â€"0.250.001â€"0.490.001Variable weightâ€"0.170.05â€"0.02NSâ€"0.06NSHamiltonâ€"0.05NSâ€"0.02NS0.12NSEarly morning wakingâ€"0.04NSâ€"0.06NSâ€"0.07NSMorning
worseningof moodâ€"0.03NSâ€"0.02NS0.06NS
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Drug groups
Statistical analyses revealed no significant differences between patients in any drug group at presentation. After six weeks of treatment, there were minor differences between groups in terms of depression ratings. There was an overall tendency for patients to gain weight, appetite and carbohy drate preference. The group of patients taking isocarboxazid and trimipramine in combination experienced greater in crease in preference for carbohydrate than the patients in all the other groups together (P <0.01). and were characterised by greater increase in weight (P <0.01).
Population as a whole
The incidence of various symptoms at presentation is shown in Table I . The population was further divided into sub-groups who had presented initially with marked increase in appetite, moderate change, and marked decrease. Similar sub-groups for weight change were examined.
Appetite sub-groups
Thirty-one subjects were identified as having marked de crease in appetite and 20 as having a marked increase at presentation. Appetite had shown a roughly normal distribu tion at presentation, with a mean of6.4, and these sub-groups were approximatelyone standard deviation or more beyond the mean.
Results were analysed in terms of paired t tests, showing the changes occurring in these appetite groups during six weeks' treatment. Unpaired t tests gave the differences between low and high appetite groups initially, at six weeks, and the differencesbetween the changesoccurringin the two groups (with direction of change taken into account).
These results are summarised in Table III . The general beneficial effect of the treatment is reflected in the Hamilton scores. At presentation, the low and high-appetite groups differed significantly in preference for carbohydrate, weight and appetite history (P <0001). The changes in score between 0 and 6 weeks for appetite, carbohydrate preference, and weight are very different in two extreme groups (they were in opposite directions). The change in weight is of interest, in that at six weeks the patients in the low-appetite group had increased in weight from 97% to 101% of their normal weight. while those in the high-appetite group had remained virtually unchanged at 106%. The significant difference in weight between the groups has now disap peared, but once again, the actual change in weight (which includes direction) is very significantly different (P <0.01).
Weight sub-groups
Twenty eight subjects were identified as having an initial weight score of 94% or less of their normal weight, and 27 as having an initial weight of 110% of their normal weight or above (where normal weight is 100%). Weight at presenta tion had shown a roughly normal distribution, with a mean weight of 102%. These sub-groups were approximately one standard deviation or more beyond the mean. At presenta tion, the significant differences between the low-and high weight groups were appetite (Table 3 P <0.001), appetite history (P <0.05), and phobic symptoms (P <0.05â€"the high weightgroupswere more phobic).
At six weeks, the only difference between the groups is one of weight, the low-weight group having nevertheless gained significantly in weight, by 3% (Table III) . This group also increased their appetite (P <0.01) and preference for carbohydrate (P <0.05), but the high-weight group has not changed significantly on these variables.
Discussion
Although the study was confined to mild to moderately depressed out-patients, changes in weight, appetite, and carbohydrate preference were strongly associated with their values at presentation, more than with the degree of depression, or with features of endogenous depression such as early morning waking and morning worsening of mood (Table II) . This was true of the whole population and also for the sub-groups with high or low weight, and high or low appetite. The reversal of appetite change is particularly interesting, since it challenges the concept of a simple pharmacological association between antidepressants and increase in appetite and carbohydrate craving. The appetite history appears to be involved, and patients whose appetite decreases as they get better, may simply be regaining control of food intake.
The importance of weight history is not so clear.
However, a previous study had shown that those patients who gained weight on becoming depressed have a history of variable weight anywayâ€"even when they are well (Harris et al, 1984) . In this smaller group of 168 patients who completed the drug trials, after six weeks there is still an association of weight change occurring with treatment with variable weight history. (Table II) . Variable weight history is often an indication of latent obesity, and the increase in appetite and weight occurring in such patients with depression may be an exaggeration of the hyperphagic reactions which the obese and latent obese often show in response to stress (Meyer & Pudel, 1977) . On the other hand, loss of weight and appetite with this depressive illness is associated with a steady weight history and hypophagic reactions to stress, the subsequent regain of appetite and weight having the same associations.
Appetite control is complex and depends upon many factors. Rodin (1978) has suggested that food intake is determined by the overall responsiveness of the individual, and this itself depends on many cues to feeding, as well as on the activity of the feeding centres in the hypothalamus. In addition, emotional factors are important, and it is well known that some individuals over-eat with anxiety or depression while others under-eat (Meyer & Pudel, 1977) . Polivy & Herman (1976) have shown the importance of restraint in the control of normal eating and also as an important principle in controlling food intake in depressed individuals. Obese people and the latently obese tend to be restrained in their eating habits, and are preoccupied with diet, weight, and food. When such individuals become depressed or anxious, restraint is lost, and there is an increase in food intake, as happened in our group of patients who presented with increased food intake. This is reversed with recovery.
It is likely, therefore, that there are at least two major variables regulating the control of appetite and hence weight in this population of depressives. Firstly, loss of restraint with depression causes an increase in appetite and weight, which is then reversed on recovery. Secondly, depression itself, directly sup pressing appetite with loss of weight, and reversal with treatment. These two factors are seen most clearly at work in the sub-groups high and low-appetite, and they are linked with appetite history and weight history (Tables II and III) . The sub-groups represent extreme ends of the spectrum, but the principles are probably at work in the population as a whole, producing a variety of appetite responses.
This study suggests that before the long-term carbohydrate craving, increase in appetite, and in crease in weight occur with antidepressant therapy, there is a simple reversal of the appetite and weight changes which occurred with depression. Further work is necessary to investigate the relationship between the long-term changes and such factors as appetite history and weight history, as well as with the pharmacological actions of various antidepressant drugs.
